"Cardiotonic Q10" Vegetable Capsule
Natural health product licensed in Canada
- Licence holder
- Absorb Science Inc.
- NPN or DIN-HM
- 80054868
- Status
- Active licence
- Licence date
- 16 October 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crataegus laevigata Source : Extrait de Feuille Potency : 2.2 % flavonoids as hyperoside | 120 mg | Not calculated |
| Crataegus laevigata Source : Fleur Potency : 2.2 % flavonoids as hyperoside | 120 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Procédé de fermentation à l'aide de levures | 60 mg | Not calculated |
| (E)-5-(p-hydroxystyryl)resorcinol Source : Fallopia japonica - Racine | 20 mg | Not calculated |
| Capsicum annuum Source : Fruit extract Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| L-carnitine Source : L-tartrate de carnitine | 250 mg | Not calculated |
| Magnésium Source : Malate de magnésium | 30 mg | 60,000 µg |
Non-medicinal ingredients
Cellulose microcristalline, Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to maintain and support cardiovascular health in adults. Helps delay fatigue during physical activity.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80054868
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.